Once-a-week pill for schizophrenia shows promise in clinical trials | MIT News | Massachusetts Institute of Technology
MIT researchers developed a pill that can be taken once a week instead of daily, gradually releasing medication from within the stomach. In a phase 3 clinical trial, the treatment maintained consistent levels of the drug risperidone in patients with schizophrenia, and it controlled their symptoms just as well as daily doses of the drug.